Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 16 Nov 2026

ZYDUSLIFE, full dossier

Zydus Lifesciences' UK-based formulations manufacturing facility received four observations from the FDA following an inspection of its LiqMeds facility from November 9 to 13.

2 publishers have reported this development. Each act of reporting is below, cited.

The record

Zydus Lifesciences' UK-based formulations manufacturing facility received four observations from the FDA following an inspection of its LiqMeds facility from November 9 to 13.

indiatimes.com16 Nov 2026

Zydus Lifesciences announced that the USFDA conducted an inspection at LiqMeds, UK from 9 to 13 November, 2026, which concluded with 4 observations.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.